Strategy Catalyst

Featured InsightsThe StrategistUpcoming EventsResource Library

Featured Insights

The Strategist

See All Newsletters

The Strategist: March 20, 2025

Subscription Required
The Strategist lead image for web

Contact Us to Gain Access
Strategist | Strategy CatalystThe Strategist in Brief: March 20, 2025

A brief summary of the top stories in this edition, including an audio version.

Subscription Required
The Strategist lead image for web

Contact Us to Gain Access
Strategist | Strategy CatalystNovo Nordisk and Eli Lilly partner with disruptors on GLP-1 D2C offerings

Novo Nordisk launched a new direct-to-consumer delivery platform for its GLP-1 weight loss medication Wegovy in partnership with Humana’s CenterWell pharmacy business, and Eli Lilly announced partnerships with Teladoc Health and LifeMD.

Subscription Required
The Strategist lead image for web

Contact Us to Gain Access
Strategist | Strategy CatalystTrump-aligned think tanks allege $1.1T in improper Medicaid payments

Two conservative think tanks widely seen as influential with the Trump administration released a paper estimating that Medicaid made $1.1T in improper payments over the past decade.

Subscription Required
The Strategist lead image for web

Contact Us to Gain Access
Strategist | Strategy CatalystUHG wins favorable ruling in DOJ lawsuit over $2B in alleged MA overpayments

UnitedHealth Group claimed a major victory in its years-long court battle with the Department of Justice over allegations that the payvider received more than $2B in overpayments through Medicare Advantage.

Subscription Required
The Strategist lead image for web

Contact Us to Gain Access
Strategist | Strategy CatalystNews Flashes, Top Reads, and Numbers: March 20, 2025

A quick roundup of recent news, top headlines, and featured numbers.

Upcoming Events

    View Full Calendar